Early-Life Environmental Exposures and Blood Pressure in Children.


Journal

Journal of the American College of Cardiology
ISSN: 1558-3597
Titre abrégé: J Am Coll Cardiol
Pays: United States
ID NLM: 8301365

Informations de publication

Date de publication:
10 09 2019
Historique:
received: 05 12 2018
revised: 26 04 2019
accepted: 24 06 2019
entrez: 7 9 2019
pubmed: 7 9 2019
medline: 20 5 2020
Statut: ppublish

Résumé

Growing evidence exists about the fetal and environmental origins of hypertension, but mainly limited to single-exposure studies. The exposome has been proposed as a more holistic approach by studying many exposures simultaneously. This study aims to evaluate the association between a wide range of prenatal and postnatal exposures and blood pressure (BP) in children. Systolic and diastolic BP were measured among 1,277 children from the European HELIX (Human Early-Life Exposome) cohort aged 6 to 11 years. Prenatal (n = 89) and postnatal (n = 128) exposures include air pollution, built environment, meteorology, natural spaces, traffic, noise, chemicals, and lifestyles. Two methods adjusted for confounders were applied: an exposome-wide association study considering the exposures independently, and the deletion-substitution-addition algorithm considering all the exposures simultaneously. Decreases in systolic BP were observed with facility density (β change for an interquartile-range increase in exposure: -1.7 mm Hg [95% confidence interval (CI): -2.5 to -0.8 mm Hg]), maternal concentrations of polychlorinated biphenyl 118 (-1.4 mm Hg [95% CI: -2.6 to -0.2 mm Hg]) and child concentrations of dichlorodiphenyldichloroethylene (DDE: -1.6 mm Hg [95% CI: -2.4 to -0.7 mm Hg]), hexachlorobenzene (-1.5 mm Hg [95% CI: -2.4 to -0.6 mm Hg]), and mono-benzyl phthalate (-0.7 mm Hg [95% CI: -1.3 to -0.1 mm Hg]), whereas increases in systolic BP were observed with outdoor temperature during pregnancy (1.6 mm Hg [95% CI: 0.2 to 2.9 mm Hg]), high fish intake during pregnancy (2.0 mm Hg [95% CI: 0.4 to 3.5 mm Hg]), maternal cotinine concentrations (1.2 mm Hg [95% CI: -0.3 to 2.8 mm Hg]), and child perfluorooctanoate concentrations (0.9 mm Hg [95% CI: 0.1 to 1.6 mm Hg]). Decreases in diastolic BP were observed with outdoor temperature at examination (-1.4 mm Hg [95% CI: -2.3 to -0.5 mm Hg]) and child DDE concentrations (-1.1 mm Hg [95% CI: -1.9 to -0.3 mm Hg]), whereas increases in diastolic BP were observed with maternal bisphenol-A concentrations (0.7 mm Hg [95% CI: 0.1 to 1.4 mm Hg]), high fish intake during pregnancy (1.2 mm Hg [95% CI: -0.2 to 2.7 mm Hg]), and child copper concentrations (0.9 mm Hg [95% CI: 0.3 to 1.6 mm Hg]). This study suggests that early-life exposure to several chemicals, as well as built environment and meteorological factors, may affect BP in children.

Sections du résumé

BACKGROUND
Growing evidence exists about the fetal and environmental origins of hypertension, but mainly limited to single-exposure studies. The exposome has been proposed as a more holistic approach by studying many exposures simultaneously.
OBJECTIVES
This study aims to evaluate the association between a wide range of prenatal and postnatal exposures and blood pressure (BP) in children.
METHODS
Systolic and diastolic BP were measured among 1,277 children from the European HELIX (Human Early-Life Exposome) cohort aged 6 to 11 years. Prenatal (n = 89) and postnatal (n = 128) exposures include air pollution, built environment, meteorology, natural spaces, traffic, noise, chemicals, and lifestyles. Two methods adjusted for confounders were applied: an exposome-wide association study considering the exposures independently, and the deletion-substitution-addition algorithm considering all the exposures simultaneously.
RESULTS
Decreases in systolic BP were observed with facility density (β change for an interquartile-range increase in exposure: -1.7 mm Hg [95% confidence interval (CI): -2.5 to -0.8 mm Hg]), maternal concentrations of polychlorinated biphenyl 118 (-1.4 mm Hg [95% CI: -2.6 to -0.2 mm Hg]) and child concentrations of dichlorodiphenyldichloroethylene (DDE: -1.6 mm Hg [95% CI: -2.4 to -0.7 mm Hg]), hexachlorobenzene (-1.5 mm Hg [95% CI: -2.4 to -0.6 mm Hg]), and mono-benzyl phthalate (-0.7 mm Hg [95% CI: -1.3 to -0.1 mm Hg]), whereas increases in systolic BP were observed with outdoor temperature during pregnancy (1.6 mm Hg [95% CI: 0.2 to 2.9 mm Hg]), high fish intake during pregnancy (2.0 mm Hg [95% CI: 0.4 to 3.5 mm Hg]), maternal cotinine concentrations (1.2 mm Hg [95% CI: -0.3 to 2.8 mm Hg]), and child perfluorooctanoate concentrations (0.9 mm Hg [95% CI: 0.1 to 1.6 mm Hg]). Decreases in diastolic BP were observed with outdoor temperature at examination (-1.4 mm Hg [95% CI: -2.3 to -0.5 mm Hg]) and child DDE concentrations (-1.1 mm Hg [95% CI: -1.9 to -0.3 mm Hg]), whereas increases in diastolic BP were observed with maternal bisphenol-A concentrations (0.7 mm Hg [95% CI: 0.1 to 1.4 mm Hg]), high fish intake during pregnancy (1.2 mm Hg [95% CI: -0.2 to 2.7 mm Hg]), and child copper concentrations (0.9 mm Hg [95% CI: 0.3 to 1.6 mm Hg]).
CONCLUSIONS
This study suggests that early-life exposure to several chemicals, as well as built environment and meteorological factors, may affect BP in children.

Identifiants

pubmed: 31488269
pii: S0735-1097(19)35959-5
doi: 10.1016/j.jacc.2019.06.069
pmc: PMC8713646
mid: NIHMS1759258
pii:
doi:

Substances chimiques

Environmental Pollutants 0
Insecticides 0
Dichlorodiphenyl Dichloroethylene 4M7FS82U08
Polychlorinated Biphenyls DFC2HB4I0K

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1317-1328

Subventions

Organisme : NIEHS NIH HHS
ID : P30 ES007048
Pays : United States
Organisme : Medical Research Council
ID : MR/K021656/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K006665/1
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : U01 NS047537
Pays : United States
Organisme : NIEHS NIH HHS
ID : N01ES75558
Pays : United States
Organisme : Medical Research Council
ID : G0601712
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Références

Stat Appl Genet Mol Biol. 2004;3:Article18
pubmed: 16646796
Pediatrics. 2004 Aug;114(2 Suppl 4th Report):555-76
pubmed: 15286277
BMJ Open. 2018 Sep 10;8(9):e021311
pubmed: 30206078
J Transl Med. 2015 Oct 15;13:327
pubmed: 26472248
Int J Environ Res Public Health. 2018 Feb 22;15(2):
pubmed: 29470452
J Clin Endocrinol Metab. 2015 Dec;100(12):4463-71
pubmed: 26469381
Eur Respir Rev. 2016 Jun;25(140):124-9
pubmed: 27246588
PPAR Res. 2010;2010:698730
pubmed: 20613959
Chemosphere. 2014 Mar;98:78-83
pubmed: 24238303
Environ Health Perspect. 2014 Jun;122(6):535-44
pubmed: 24610234
J Hypertens. 2009 Sep;27(9):1719-42
pubmed: 19625970
Pediatr Res. 2018 Aug;84(2):165-180
pubmed: 29884847
Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
Int J Epidemiol. 2012 Feb;41(1):24-32
pubmed: 22296988
Environ Health Perspect. 2015 Oct;123(10):1015-21
pubmed: 25910281
Environ Health Perspect. 2017 Sep 20;125(9):097018
pubmed: 28934720
Hypertension. 2015 Aug;66(2):301-8
pubmed: 26156503
Pediatr Nephrol. 2013 Dec;28(12):2343-9
pubmed: 23868109
Hypertension. 2017 Feb;69(2):367-374
pubmed: 27920131
Pharmacol Res. 2018 Jun;132:160-167
pubmed: 29684673
Hum Genet. 2012 May;131(5):747-56
pubmed: 22143225
Nat Rev Cardiol. 2018 Jul;15(7):432-438
pubmed: 29654256
Environ Pollut. 2018 Apr;235:576-588
pubmed: 29331891
Environ Int. 2018 Dec;121(Pt 1):751-763
pubmed: 30326459
Crit Rev Toxicol. 2008;38(10):877-93
pubmed: 19012089
J Dev Orig Health Dis. 2018 Apr;9(2):208-214
pubmed: 29103408
Curr Environ Health Rep. 2015 Dec;2(4):367-78
pubmed: 26341623
J Pediatr. 2013 Sep;163(3):747-53.e1
pubmed: 23706605
J Clin Hypertens (Greenwich). 2011 Nov;13(11):836-42
pubmed: 22051429
Int J Environ Res Public Health. 2016 Feb 29;13(3):
pubmed: 26938545
Physiol Rev. 2016 Apr;96(2):549-603
pubmed: 26887677
Int J Epidemiol. 2016 Apr;45(2):382-8
pubmed: 27063603
Environ Int. 2019 Feb;123:189-200
pubmed: 30530161
Sci Total Environ. 2017 Jan 1;575:276-286
pubmed: 27750133
J Trace Elem Med Biol. 2016 May;35:107-15
pubmed: 27049134
Eur Heart J. 2018 Sep 1;39(33):3021-3104
pubmed: 30165516
Environ Res. 2016 Apr;146:379-87
pubmed: 26821262
Toxicol Sci. 2004 Nov;82(1):170-82
pubmed: 15310864
Environ Health Perspect. 2015 Oct;123(10):1022-9
pubmed: 25850106
Environ Sci Pollut Res Int. 2018 Jun;25(17):16951-16958
pubmed: 29623647
Environ Health Perspect. 2016 Dec;124(12):1848-1856
pubmed: 27219331

Auteurs

Charline Warembourg (C)

ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiologa y Salud Pública, Madrid, Spain.

Léa Maitre (L)

ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiologa y Salud Pública, Madrid, Spain.

Ibon Tamayo-Uria (I)

ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiologa y Salud Pública, Madrid, Spain.

Serena Fossati (S)

ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiologa y Salud Pública, Madrid, Spain.

Theano Roumeliotaki (T)

Department of Social Medicine, Faculty of Medicine, University of Crete, Heraklion, Greece.

Gunn Marit Aasvang (GM)

Norwegian Institute of Public Health, Oslo, Norway.

Sandra Andrusaityte (S)

Vytauto Didziojo Universitetas, Kaunus, Lithuania.

Maribel Casas (M)

ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiologa y Salud Pública, Madrid, Spain.

Enrique Cequier (E)

Norwegian Institute of Public Health, Oslo, Norway.

Lida Chatzi (L)

Department of Social Medicine, Faculty of Medicine, University of Crete, Heraklion, Greece; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California; Department of Genetics and Cell Biology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands.

Audrius Dedele (A)

Vytauto Didziojo Universitetas, Kaunus, Lithuania.

Juan-Ramon Gonzalez (JR)

ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiologa y Salud Pública, Madrid, Spain.

Regina Gražulevičienė (R)

Vytauto Didziojo Universitetas, Kaunus, Lithuania.

Line Smastuen Haug (LS)

Norwegian Institute of Public Health, Oslo, Norway.

Carles Hernandez-Ferrer (C)

ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiologa y Salud Pública, Madrid, Spain.

Barbara Heude (B)

INSERM, UMR1153 Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), Early ORigins of the Child's Health and Development Team (ORCHAD), Paris Descartes University, Paris, France.

Marianna Karachaliou (M)

Department of Social Medicine, Faculty of Medicine, University of Crete, Heraklion, Greece.

Norun Hjertager Krog (NH)

Norwegian Institute of Public Health, Oslo, Norway.

Rosemary McEachan (R)

Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, United Kingdom.

Mark Nieuwenhuijsen (M)

ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiologa y Salud Pública, Madrid, Spain.

Inga Petraviciene (I)

Vytauto Didziojo Universitetas, Kaunus, Lithuania.

Joane Quentin (J)

Inserm, Université Grenoble Alpes, CNRS, Institute of Advanced Biosciences, Team of Environmental Epidemiology applied to Reproduction and Respiratory Health, Grenoble, France; CHU Grenoble Alpes, Grenoble, France.

Oliver Robinson (O)

MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London, United Kingdom.

Amrit Kaur Sakhi (AK)

Norwegian Institute of Public Health, Oslo, Norway.

Rémy Slama (R)

Inserm, Université Grenoble Alpes, CNRS, Institute of Advanced Biosciences, Team of Environmental Epidemiology applied to Reproduction and Respiratory Health, Grenoble, France.

Cathrine Thomsen (C)

Norwegian Institute of Public Health, Oslo, Norway.

Jose Urquiza (J)

ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiologa y Salud Pública, Madrid, Spain.

Marina Vafeiadi (M)

Department of Social Medicine, Faculty of Medicine, University of Crete, Heraklion, Greece.

Jane West (J)

Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, United Kingdom.

John Wright (J)

Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, United Kingdom.

Martine Vrijheid (M)

ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiologa y Salud Pública, Madrid, Spain.

Xavier Basagaña (X)

ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiologa y Salud Pública, Madrid, Spain. Electronic address: xavier.basagana@isglobal.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH